Here's Why Amyris Stock Plunged 54% in November
After climbing 8% in October, shares of Amyris (NASDAQ: AMRS) took a sharp U-turn in November. Investors' hopes are high as this synthetic biology company attempts to develop sustainable ingredients for consumer products, but a weak earnings report (among other issues) proved too much for investors to handle.
Shares of Amyris plunged precipitously in November and ended the month 54% lower than where they began, according to data from S&P Global Market Intelligence.
Source Fool.com